Weed Inc. (BUDZ)

Overview

WEED, Inc. is a dynamic entity engaged in the systematic examination and application of cannabis-derived compounds for addressing both human illnesses and animal health issues. Its scope of work extends beyond mere research as it encompasses the cultivation and harvesting of cannabis and hemp for the purpose of product innovation, processing, manufacturing, and the marketing of both pharmaceutical and non-pharmaceutical products. Initially established under the name United Mines, Inc., the company underwent a significant rebranding to WEED, Inc. in February 2015, marking a pivotal shift in its corporate identity and focus area. Since its inception in 1999, WEED, Inc. has rooted itself in Tucson, Arizona, from where it aims to spearhead advancements in the medical cannabis and hemp sectors, reflecting its commitment towards leveraging the therapeutic potentials of these plants.

Products and Services

WEED, Inc. caters to a diversified portfolio comprising of both pharmaceutical and non-pharmaceutical offerings aimed at exploiting the therapeutic values of cannabis and hemp. Notably, its operations span across several facets of the cannabis and hemp industry:

• Research and Development: The company places a strong emphasis on the exploration and development of cannabis-derived compounds. This involves rigorous scientific research aimed at understanding the medicinal properties of cannabis and hemp, thereby leading to the creation of innovative treatments for a variety of human and animal ailments.
• Cultivation and Harvesting: Integral to its product development process, WEED, Inc. engages in the cultivation and harvesting of cannabis and hemp. This is done with a view to ensure high-quality plants that are then processed for their medicinal compounds, underpinning the company's product portfolio.
• Pharmaceutical Products: Leveraging the findings from its research and development activities, the company manufactures pharmaceutical products that target specific medical conditions. These products are formulated using compounds derived from cannabis and hemp, reflecting the company’s commitment to introducing innovative medical solutions into the market.
• Non-Pharmaceutical Products: Beyond its pharmaceutical ventures, WEED, Inc. also develops and markets a range of non-pharmaceutical products. These include a variety of services and therapeutics designed to enhance the health and wellbeing of individuals, without the direct application of pharmaceutical compounds.
• Therapeutics and Treatments for Medical Cannabis and Hemp Markets: The company is actively involved in the creation and distribution of therapeutics and treatments specifically tailored for the medical cannabis and hemp sectors. This encompasses a broad spectrum of products and services designed to cater to the nuanced needs of these rapidly evolving markets.